News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
424,517 Results
Type
Article (29748)
Company Profile (302)
Press Release (394467)
Section
Business (118586)
Career Advice (734)
Deals (19788)
Drug Delivery (63)
Drug Development (68638)
Employer Resources (57)
FDA (10376)
Job Trends (8627)
News (215540)
Policy (18720)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (3)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (7)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (4)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
Academia (2145)
Accelerated approval (2)
Adcomms (24)
Allergies (64)
Alliances (31159)
ALS (75)
Alzheimer's disease (1301)
Antibody-drug conjugate (ADC) (105)
Approvals (10377)
Artificial intelligence (148)
Autoimmune disease (10)
Automation (7)
Bankruptcy (184)
Best Places to Work (7593)
BIOSECURE Act (7)
Biosimilars (53)
Biotechnology (247)
Bladder cancer (49)
Brain cancer (23)
Breast cancer (208)
Cancer (1579)
Cardiovascular disease (135)
Career advice (608)
Career pathing (14)
CAR-T (128)
Cell therapy (348)
Cervical cancer (10)
Clinical research (55073)
Collaboration (592)
Compensation (285)
Complete response letters (19)
COVID-19 (2018)
CRISPR (38)
C-suite (157)
Cystic fibrosis (96)
Data (1638)
Denatured (12)
Depression (36)
Diabetes (194)
Diagnostics (3437)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (20)
Drug discovery (96)
Drug pricing (54)
Drug shortages (17)
Duchenne muscular dystrophy (73)
Earnings (46282)
Editorial (20)
Employer branding (5)
Employer resources (53)
Events (68756)
Executive appointments (457)
FDA (11185)
Featured Employer (38)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (544)
Gene editing (90)
Generative AI (15)
Gene therapy (272)
GLP-1 (539)
Government (2769)
Grass and pollen (2)
Guidances (32)
Healthcare (12302)
Huntington's disease (23)
IgA nephropathy (23)
Immunology and inflammation (86)
Indications (22)
Infectious disease (2110)
Inflammatory bowel disease (126)
Inflation Reduction Act (9)
Influenza (29)
Intellectual property (65)
Interviews (100)
IPO (10411)
IRA (22)
Job creations (1432)
Job search strategy (554)
Kidney cancer (7)
Labor market (9)
Layoffs (277)
Leadership (7)
Legal (3089)
Liver cancer (45)
Lung cancer (224)
Lymphoma (109)
Machine learning (2)
Management (18)
Manufacturing (157)
MASH (61)
Medical device (6418)
Medtech (6419)
Mergers & acquisitions (9696)
Metabolic disorders (504)
Multiple sclerosis (56)
NASH (21)
Neurodegenerative disease (73)
Neuropsychiatric disorders (26)
Neuroscience (1728)
NextGen: Class of 2025 (3741)
Non-profit (2530)
Northern California (1794)
Now hiring (32)
Obesity (260)
Opinion (146)
Ovarian cancer (58)
Pain (65)
Pancreatic cancer (61)
Parkinson's disease (118)
Partnered (9)
Patents (142)
Patient recruitment (76)
Peanut (42)
People (35692)
Pharmaceutical (52)
Pharmacy benefit managers (9)
Phase I (17977)
Phase II (24682)
Phase III (17515)
Pipeline (746)
Podcasts (51)
Policy (56)
Postmarket research (1805)
Preclinical (7796)
Press Release (57)
Prostate cancer (69)
Psychedelics (36)
Radiopharmaceuticals (224)
Rare diseases (331)
Real estate (2406)
Recruiting (21)
Regulatory (14317)
Reports (16)
Research institute (1729)
Resumes & cover letters (116)
Rett syndrome (3)
RNA editing (2)
RSV (27)
Schizophrenia (61)
Series A (96)
Series B (59)
Service/supplier (5)
Sickle cell disease (43)
Southern California (1575)
Special edition (11)
Sponsored (20)
Startups (2481)
State (1)
Stomach cancer (9)
Supply chain (33)
The Weekly (39)
United States (15146)
Vaccines (467)
Venture capitalists (29)
Webinars (8)
Weight loss (161)
Women's health (18)
Worklife (5)
Date
Today (96)
Last 7 days (478)
Last 30 days (2307)
Last 365 days (26624)
2025 (4989)
2024 (27350)
2023 (30379)
2022 (37576)
2021 (39975)
2020 (36057)
2019 (28493)
2018 (21340)
2017 (21518)
2016 (19853)
2015 (23591)
2014 (17267)
2013 (13523)
2012 (14078)
2011 (14532)
2010 (13342)
Location
Africa (340)
Alabama (41)
Alaska (3)
Arizona (85)
Arkansas (6)
Asia (24562)
Australia (4578)
California (4093)
Canada (1357)
China (339)
Colorado (168)
Connecticut (203)
Delaware (110)
Europe (57034)
Florida (534)
Georgia (133)
Idaho (31)
Illinois (302)
India (14)
Indiana (162)
Iowa (3)
Japan (108)
Kansas (68)
Kentucky (13)
Louisiana (8)
Maine (34)
Maryland (590)
Massachusetts (3188)
Michigan (116)
Minnesota (218)
Mississippi (1)
Missouri (43)
Montana (22)
Nebraska (14)
Nevada (31)
New Hampshire (33)
New Jersey (1197)
New Mexico (15)
New York (1167)
North Carolina (658)
North Dakota (7)
Northern California (1794)
Ohio (123)
Oklahoma (8)
Oregon (28)
Pennsylvania (864)
Puerto Rico (5)
Rhode Island (14)
South America (481)
South Carolina (7)
South Dakota (1)
Southern California (1575)
Tennessee (61)
Texas (569)
Utah (100)
Virginia (94)
Washington D.C. (34)
Washington State (418)
West Virginia (1)
Wisconsin (26)
424,517 Results for "plasma protein therapeutics association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Streck launches Protein Plus BCTTM for stabilization of plasma proteins in whole blood
LaVista, Nebraska – Streck is pleased to announce the launch of Protein Plus BCTTM, a direct draw whole blood collection tube intended for the stabilization of draw-time concentrations of plasma proteins during ambient temperature storage. Protein Plus BCT is For Research Use Only. Not for use in diagnostic procedures.
April 8, 2024
·
1 min read
BioMidwest
LFB Plasma Joins Plasma Protein Therapeutics Association (PPTA)
LFB Plasma, a US-based plasma collection company and subsidiary of the LFB Group, a leading European company providing plasma-derived products to healthcare professionals, announces joining the Plasma Protein Therapeutics Association.
September 9, 2022
·
2 min read
Press Releases
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
March 6, 2025
·
3 min read
Press Releases
Argobio and the Institut Pasteur Launch Enodia Therapeutics: A Biotech Company With a New Approach for Targeted Protein Degradation
February 26, 2025
·
5 min read
Press Releases
Peptone Announces Key Leadership Appointments to Progress Novel Protein Structural Insights for Intrinsically Disordered Protein-Driven Therapeutics
January 10, 2025
·
5 min read
Genetown
Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting
Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.
May 1, 2024
·
3 min read
Press Releases
Be Biopharma Announces Publication of Manuscript in the Molecular Therapy Journal Demonstrating In Vivo Engraftment and Tracking of Ex-vivo-Generated Plasma Cells in Non-Human Primates
February 6, 2025
·
3 min read
Sponsored
SignalChem’s Tau Proteins: Accelerating Neurodegenerative Disease Research
SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.
November 18, 2024
·
3 min read
Press Releases
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
January 14, 2025
·
7 min read
Genetown
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
Biognosys, a leader in next-generation proteomics services, software and kits for life sciences research and drug development, announced the launch of the novel, proprietary P2 Plasma Enrichment method for single-well, single particle-type enrichment with market leading performance and sensible, superior economics.
May 30, 2024
·
6 min read
1 of 42,452
Next
